Crossmark

Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials

Crossref DOI link: https://doi.org/10.1136/bmjonc-2023-000229

Published Online: 2024-03-19

Published Print: 2024-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Dennis, Brody https://orcid.org/0000-0002-5840-1507
Bratten, Chance

Hughes, Griffin K

Peña, Andriana M

McIntire, Ryan https://orcid.org/0000-0002-1447-3832
Ladd, Chase

Gardner, Brooke

Nowlin, William

Livingston, Reagan

Tuia, Jordan

Haslam, Alyson

Prasad, Vinay

Vassar, Matt
License Information

License valid from 2024-03-19